Rhode Island HB 5679: AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE PRESCRIPTION DRUG SALES REPRESENTATIVE DISCLOSURE ACT (Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name on list.)

Status: 03/15/2023 Committee recommended measure be held for further study (as of 2023-03-15)

State: Rhode Island · Session: 2023 · Bill: HB 5679

Subjects: Business & Professions, Drugs, Fees, Health Care Affordability, Prescription drugs

Sponsors: Batista, Casey, Cotter, Cruz, Giraldo, Kislak, McNamara, Morales, Potter, Stewart

View Rhode Island HB 5679 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.